Table 5. Reviews of the other miRNA-machinery gene polymorphisms studied in regard to cancer risk.
| Gene | SNP | Position | Cancer type | Citation |
|---|---|---|---|---|
| XPO5 | rs11077 (A > G) | 3′-UTR | EC, BC, CRC, TC, RCC, bladder, and larynx cancer | [2,14,15,25,29–34] |
| RAN | rs14035 (C > T) | 3′-UTR | RCC, LC, CRC, EC, GC, OC, and larynx cancer | [14,15,24,25,29,32–35] |
| rs3803012 (A > G) | 3′-UTR | BC, HNC, CC, and HCC | [2,36–38] | |
| rs3809142 (C > T) | Upstream | BC | [2] | |
| rs7301722 (C > A) | Upstream | BC | [2] | |
| rs7958223 (C > A) | Intron | BC | [31] | |
| rs10848236 (G > A) | Intron | BC | [31] | |
| DICER1 | rs1057035 (T > C) | 3′-UTR | BC | [2,31] |
| rs3742330 (A > G) | 3′UTR | PC, LC, and larynx cancer | [15,25,39] | |
| rs2282265 (A > G) | Intron | BC | [31] | |
| rs13078 (T > A) | 3′-UTR | LC and larynx | [15,25] | |
| TARBP2 | rs784567 (A > G) | 5′-UTR | PC and larynx | [25] |
| rs2280448 (C > T) | 5′-UTR | BC | [31] | |
| AGO1 | rs595055 (G > A) | Intron | BC | [31] |
| rs11263833 (T > G) | Intron | BC | [31] | |
| rs636832 (A > G) | Intron | LC | [15] | |
| rs595961 (G > A) | Intron | LC and RCC | [14,15] | |
| AGO2 | rs4961280 (A > C) | Upstream | PC | [39] |
| rs77216619 (G/T) | Intron | BC | [2] | |
| rs78796470 (C > T) | Intron | BC | [2] | |
| rs2292779 (G > C) | Intron | BC | [31] | |
| rs3864659 (A > C) | Intron | BC | [31] | |
| rs7016981 (T > C) | Intron | BC | [31] | |
| rs7824304 (C > T) | Intron | BC | [31] | |
| rs11786030 (A > G) | 3′-UTR | BC | [31] | |
| HIWI | rs10773771 (T > C) | 3′-UTR | BC | [2] |
| rs4759659 (G > A) | Intron | BC | [31] | |
| rs7963072 (G > A) | Intron | BC | [31] | |
| rs1106042 (G > A) | Exon (K527R) | BC and LC | [15,31] | |
| rs11060845 (G > T) | Intron | BC | [31] | |
| GEMIN3 | rs197414 (C > A) | Exon (S693R) | PC, BC, and LC | [15] |
| rs197388 (T > A) | Upstream | LC | [15] | |
| rs197412 (T > C) | Exon (T636I) | LC, RCC, and OC | [14,15,35] | |
| rs11584657 (C > T) | Upstream | BC | [2] | |
| rs17504173 (A > G) | 3′-UTR | BC | [2] | |
| rs197413 (G > A) | Exon (V642V) | BC | [31] | |
| rs17569368 (A > T) | Intron | BC | [31] | |
| GEMIN4 | rs7813 (C > T) | Exon (C1033R) | PC,BC, LC, and RCC | [14,15,31] |
| rs3744741 (C > T) | Exon (R684Q) | BC and LC | [2,15,31] | |
| rs4968104 (T > A) | Exon (V593E) | BC and LC | [2,15,31] | |
| rs2251689 (G > A) | Upstream | BC | [2] | |
| rs2740348 (C > G) | Exon (E450Q) | BC and LC | [15] | |
| rs910924 (C > T) | Upstream | LC | [15] | |
| rs910925 (G > C) | Exon (G579A) | LC | [15] | |
| rs1062923 (T > C) | Exon (T739I) | LC | [15] | |
| rs2740349 (A > G) | Exon (N929D) | BC | [31] | |
| FMR1 | rs25704 (T > C) | 3′-UTR | BC | [31] |
| rs28900 (A > C) | Intron | BC | [31] | |
| rs971000 (C > T) | Intron | BC | [31] |
Abbreviations: BC, breast cancer; CC, cervical cancer; CRC, colorectal cancer; EC, esophageal cancer; GC, gastric cancer; HCC, hepatocellular carcinoma; HNC, head and neck cancer; LC, lung cancer; OC, oral cancer; PC, prostate cancer; RCC, renal cell carcinoma; TC, thyroid cancer.